Moxifloxacin Hydrochloride Monohydrate
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| A-S Medication Solutions | repackager | 2 | SUPPLYING |
| Direct_Rx | repackager | 2 | SUPPLYING |
| Redpharm Drug | repackager | 2 | SUPPLYING |
| ADVANCED RX PHARMACY OF TENNESSEE, LLC | repackager | 2 | SUPPLYING |
| Golden State Medical Supply, Inc. | repackager | 1 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | generic | 1 | SUPPLYING |
| Apotex Corp. | generic | 1 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 1 | SUPPLYING |
| Lifestar Pharma LLC | unknown | 1 | SUPPLYING |
| NorthStar Rx LLC | relabeler | 1 | SUPPLYING |
| Proficient Rx LP | repackager | 1 | SUPPLYING |
| Aurobindo Pharma Limited | generic | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Failed Impurities/Degradation Specifications — Recalling firm: Aurobindo Pharma USA Inc. — USA Nationwide
Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution. — Recalling firm: AuroMedics Pharma LLC — Nationwide in the U.S.
Failed Impurities/Degradation Specifications: Expansion of July 2018 and February 2019 recall due to high out-of-specification for impurities. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide in the USA and Puerto Rico.
Failed Impurities/Degradation Specifications: Out of specification test results in related substance at three-month long term stability study was obtained. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed by 5 wholesalers, 6 drug chains, 4 mail order pharmacies and 1 mail order pharmacy/supermarket …
Failed Impurities/Degradation Specifications: An out-of-specification result in the related substance test during three month long-term stability study. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed throughout the United States
